Rogan Nunn is General Counsel and Secretary. Prior to joining OnKure, Mr. Nunn served as General Counsel, America at ADC Therapeutics, where he oversaw global legal operations and executed transactions across the U.S., Europe and Asia. Before ADC, he served as EVP, General Counsel and Secretary of Array BioPharma Inc. until Array’s sale to Pfizer. Prior to moving in-house, Mr. Nunn was a corporate and M&A specialist at Skadden, Arps, where he counseled boards and executive teams of both public and private companies in a diverse array of corporate matters, with a particular focus on life sciences and biotechnology. He has also held positions at Morgan Stanley and KPMG. Mr. Nunn holds a BS in Finance and International Business from Georgetown University and a Juris Doctor from the University of Virginia School of Law.
